Organic sodium salts
Sigma Aldrich Fine Chemicals Biosciences Heparin sodium salt from porcine intestinal mucosa|9041-08-1 | MFCD00081689 | 50ku
Heparin sodium salt from porcine intestinal mucosaPurity: MW: | 9041-08-1 | MFCD00081689 | 50ku
Sigma Aldrich Fine Chemicals Biosciences Heparin sodium salt from porcine intestinal mucosa | 9041-08-1 | MFCD00081689 | 25ku
Heparin sodium salt from porcine intestinal mucosaPurity: MW: | 9041-08-1 | MFCD00081689 | 25ku
Sigma Aldrich Fine Chemicals Biosciences Poly-L-glutamic acid sodium salt | 26247-79-0 | MFCD00081868 | 25mg
Poly-L-glutamic acid sodium salt | Mol Wt: 15,000-50,000 | 26247-79-0 | MFCD00081868 | 25mg
Sigma Aldrich Fine Chemicals Biosciences Heparin sodium salt from porcine intestinal mucosa Grade I-A, ≥180 USP units/mg, powder, BioReagent, suitable for cell culture | 9041-08-1 | MFCD00081689 | 250ku
Heparin sodium salt from porcine intestinal mucosa Grade I-A, ≥180 USP units/mg, powder, BioReagent, suitable for cell culture | 9041-08-1 | MFCD00081689 | 250ku
Sigma Aldrich Fine Chemicals Biosciences Carbenicillin disodium salt anhydrous basis | 4800-94-6 | MFCD00077683 | 1g
Carbenicillin disodium salt anhydrous basis | Purity: 89.0-100.5% | Mol Wt: 422.36 | 4800-94-6 | MFCD00077683 | 1g
Sigma Aldrich Fine Chemicals Biosciences Carbenicillin disodium salt | 4800-94-6 | MFCD00077683 | 1g
Carbenicillin disodium salt | Mol Wt: 422.36 | 4800-94-6 | MFCD00077683 | 1g
Sigma Aldrich Fine Chemicals Biosciences Cefotaxime Sodium Salt | 64485-93-4 | MFCD00079073 | 1g
Cefotaxime Sodium Salt | Mol Wt: 477.45 | 64485-93-4 | MFCD00079073 | 1g
Sigma Aldrich Fine Chemicals Biosciences Carbenicillin disodium salt | 4800-94-6 | MFCD00077683 | 5 g
Carbenicillin disodium salt | Purity: 89.0-100.5% | Mol Wt: 422.36 | 4800-94-6 | MFCD00077683 | 5 g
Apexbio Technology LLC NBQX 118876-58-7 50mg
NBQX (CAS 118876-58-7) is a potent and selective antagonist of AMPA-type ionotropic glutamate receptors By inhibiting AMPA-mediated excitatory synaptic transmission NBQX disrupts glutamate-induced neuronal signaling thereby attenuating neuronal injury associated with excessive neurotransmitter release This compound has been widely utilized in preclinical studies to investigate neuroprotective and anticonvulsant mechanisms as well as to model and analyze the pathophysiology of neurodegenerative diseases epilepsy and other central nervous system disorders
![eMolecules Decanoic acid, sodium salt (1:1) | A2B Chem LLC | 1002-62-6 | MFCD00066453 | 194.250 | C10H19NaO2 | 98.000 | [Na+].CCCCCCCCCC([O-])=O | 25g | 523599416](https://assets.fishersci.com/TFS-Assets/CCG/product-images/NC2307456.JPG-250.jpg)
eMolecules Decanoic acid, sodium salt (1:1) | A2B Chem LLC | 1002-62-6 | MFCD00066453 | 194.250 | C10H19NaO2 | 98.000 | [Na+].CCCCCCCCCC([O-])=O | 25g | 523599416
Decanoic acid, sodium salt (1:1) | A2B Chem LLC | 1002-62-6 | MFCD00066453 | 194.250 | C10H19NaO2 | 98.000 | [Na+].CCCCCCCCCC([O-])=O | 25g | 523599416
Selleck Chemical LLC Sodium Glucoheptonate Dihydrate S2587-25mg
Sodium glucoheptonate is used for cleaning metal mercerizing paint stripping and aluminum etching
Medchemexpress LLC Benzo[f]quinoxaline-7-sulfonamide, 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo- | 118876-58-7 | C12H8N4O6S | 100 MG
NBQX is a highly selective and competitive AMPA receptor antagonist with demonstrated neuroprotective and anticonvulsant activity.
- Highly selective and competitive AMPA receptor antagonist.
- Exhibits high affinity for AMPA and kainate binding sites.
- Minimal or no affinity for the glutamate recognition site on the NMDA receptor complex.
- Decreases seizures induced by PTZ.
- Neuroprotective in a focal ischaemia model.
Apexbio Technology LLC DIBUTYRYL-CAMP SODI. SALT 50MG
DIBUTYRYL-CAMP SODI. SALT 50MG APEXBIO TECHNOLOGIES
Medchemexpress LLC NBQX disodium | 479347-86-9 | C12H6N4Na2O6S | 5 MG
NBQX disodium is a highly selective and competitive AMPA receptor antagonist. It exhibits neuroprotective and anticonvulsant activity by targeting AMPA and kainate binding sites, with minimal affinity for the glutamate recognition site on the NMDA receptor complex. It has demonstrated efficacy in decreasing PTZ-induced seizures and neuroprotection in focal ischemia models.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective activity
- Shows anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Minimal affinity for the glutamate recognition site on the NMDA receptor complex
- Decreases seizures induced by PTZ
- Neuroprotective in focal ischemia models